ARCHIVES

FDA Softening Its Stance On CME Guidelines; New Version To Be More In Line with ACCME

This article is from The Cancer Letter archive.

Vol. 18 No. 14 | April 3, 1992

Download PDF Visit The Full Archive

Related Articles

ASCO Annual Meeting: New Regimens Promising For Metastatic Colon Cancer

July 28, 2006

NCI to Study Review Group’s report Urging Restructure of Prevention Programm

June 27, 1997

NCI advisors approve recompetition of $62 million phase II contracts program.

November 19, 2004

In Brief: ACS Board Names McGinnis Prsident; Fuller Re-Elected chairman; Lenhard Is Vice President

November 25, 1994

RFAs Available: Silicone And Immune Response; Role Of Metallotionein; Dietary Fat Biomarkers

September 11, 1992

Rush-Presbyterian Professor Committed Misconduct, ORI Says

October 6, 1995